[2] It is available as a lyophilized powder for injection in 10-mL glass vials containing pantoprazole sodium salt (equivalent to 40 ... formulations of other PPIs, such as omeprazole and ...
Atea Pharmaceuticals, Inc. (NASDAQ: AVIR) Q4 2024 Earnings Call Transcript March 6, 2025 Atea Pharmaceuticals, Inc. misses on ...
Over an estimated 120 million covered lives have access to VOQUEZNA tablets, representing coverage for over 80% of U.S. commercial lives, many of which only require one step through a prior proton ...
The U.S. Producer Price Index fell 0.1% M/M in February, compared with the +0.3% consensus and decelerated from +0.5% in ...
I read your recent column on the use of proton-pump inhibitors (PPIs ... After about three months, my primary doctor reduced it to 20 mg a day. My symptoms are still good, and I’m still ...
Acid reducing medicines from the group of proton pump inhibitors (PPIs) are best-selling drugs that prevent and alleviate stomach problems. PPIs are activated in the acid-producing cells of the ...
The PPI index was unchanged from January, and rose 3.2% for the 12 months ended in February, according to Bureau of Labor Statistics data released Thursday. That marked a sharp slowdown from ...
The Food and Drug Administration (FDA) has approved Arbli™, an oral suspension formulation of losartan potassium.  Arbli, an angiotensin II receptor blocker, is indicated for the treatment of ...
Acid reducing medicines from the group of proton pump inhibitors (PPIs) are best-selling drugs that prevent and alleviate stomach problems. PPIs are activated in the acid-producing cells of the ...
An updated guideline has been published by the AHA, ACC, and other organizations regarding the management of acute coronary syndrome.